SBI Securities Co. Ltd. acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 31,369 shares of the health services provider’s stock, valued at approximately $285,000.
Several other large investors have also recently bought and sold shares of TDOC. Private Advisor Group LLC lifted its holdings in Teladoc Health by 26.9% during the 3rd quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider’s stock worth $128,000 after buying an additional 2,962 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Teladoc Health by 693.0% during the 3rd quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider’s stock worth $214,000 after buying an additional 20,361 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in Teladoc Health during the 3rd quarter worth $111,000. Janney Montgomery Scott LLC lifted its holdings in Teladoc Health by 63.0% during the 3rd quarter. Janney Montgomery Scott LLC now owns 106,727 shares of the health services provider’s stock worth $980,000 after buying an additional 41,250 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its holdings in Teladoc Health by 141.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider’s stock worth $5,279,000 after buying an additional 337,305 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.
Analyst Ratings Changes
TDOC has been the topic of several research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Royal Bank of Canada increased their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $11.26.
Teladoc Health Price Performance
TDOC opened at $9.06 on Thursday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $15.95. The company has a fifty day simple moving average of $10.63 and a 200 day simple moving average of $9.62. The stock has a market cap of $1.57 billion, a P/E ratio of -1.57 and a beta of 1.27.
Teladoc Health (NYSE:TDOC – Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.
Teladoc Health Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Why Are These Companies Considered Blue Chips?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.